These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26965004)

  • 21. The effect of pH and organic ester penetration enhancers on skin permeation kinetics of terbutaline sulfate from pseudolatex-type transdermal delivery systems through mouse and human cadaver skins.
    Panigrahi L; Pattnaik S; Ghosal SK
    AAPS PharmSciTech; 2005 Sep; 6(2):E167-73. PubMed ID: 16353974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.
    Cho CW; Choi JS; Yang KH; Shin SC
    Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of Skin Permeation of a Hydrophilic Drug from Acryl-Based Pressure-Sensitive Adhesive Tape.
    Suzuki T; Aoki T; Saito M; Hijikuro I; Itakura S; Todo H; Sugibayashi K
    Pharm Res; 2021 Feb; 38(2):289-299. PubMed ID: 33515137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence of marketed transdermal delivery systems for tulobuterol.
    Tojo K; Hikima T
    Biol Pharm Bull; 2007 Aug; 30(8):1576-9. PubMed ID: 17666825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of the enhancement effect of the natural transdermal permeation enhancers from Ledum palustre L. var. angustum N. Busch: Mechanistic insight based on interaction among drug, enhancers and skin.
    Nan L; Liu C; Li Q; Wan X; Guo J; Quan P; Fang L
    Eur J Pharm Sci; 2018 Nov; 124():105-113. PubMed ID: 30153525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of monolithic matrix patch system containing tulobuterol.
    Rhee YS; Kwon SY; Park CW; Choi NY; Byun WJ; Chi SC; Park ES
    Arch Pharm Res; 2008 Aug; 31(8):1029-34. PubMed ID: 18787793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and cytotoxicity evaluation of biocompatible amino acid esters used to convert salicylic acid into ionic liquids.
    Moshikur RM; Chowdhury MR; Wakabayashi R; Tahara Y; Moniruzzaman M; Goto M
    Int J Pharm; 2018 Jul; 546(1-2):31-38. PubMed ID: 29751143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ionic liquids as ingredients in topical drug delivery systems.
    Dobler D; Schmidts T; Klingenhöfer I; Runkel F
    Int J Pharm; 2013 Jan; 441(1-2):620-7. PubMed ID: 23123180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of menthone and related compounds on skin permeation of drugs with different lipophilicity and molecular organization of stratum corneum lipids.
    Lan Y; Wang J; Li H; Zhang Y; Chen Y; Zhao B; Wu Q
    Pharm Dev Technol; 2016; 21(4):389-98. PubMed ID: 25684238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amino acid derivatives as transdermal permeation enhancers.
    Janůšová B; Skolová B; Tükörová K; Wojnarová L; Simůnek T; Mladěnka P; Filipský T; Ríha M; Roh J; Palát K; Hrabálek A; Vávrová K
    J Control Release; 2013 Jan; 165(2):91-100. PubMed ID: 23154194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal insulin delivery using choline-based ionic liquids (CAGE).
    Tanner EEL; Ibsen KN; Mitragotri S
    J Control Release; 2018 Sep; 286():137-144. PubMed ID: 30026081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural products as potential drug permeation enhancer in transdermal drug delivery system.
    Patil UK; Saraogi R
    Arch Dermatol Res; 2014 Jul; 306(5):419-26. PubMed ID: 24481830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced transdermal delivery of loratadine from the EVA matrix.
    Cho CW; Choi JS; Kim SJ; Shin SC
    Drug Deliv; 2009 May; 16(4):230-5. PubMed ID: 19514983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors.
    Tsai JC; Guy RH; Thornfeldt CR; Gao WN; Feingold KR; Elias PM
    J Pharm Sci; 1996 Jun; 85(6):643-8. PubMed ID: 8773963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design Principles of Ionic Liquids for Transdermal Drug Delivery.
    Tanner EEL; Curreri AM; Balkaran JPR; Selig-Wober NC; Yang AB; Kendig C; Fluhr MP; Kim N; Mitragotri S
    Adv Mater; 2019 Jul; 31(27):e1901103. PubMed ID: 31112631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biocompatible Ionic Liquid Enhances Transdermal Antigen Peptide Delivery and Preventive Vaccination Effect.
    Tahara Y; Morita K; Wakabayashi R; Kamiya N; Goto M
    Mol Pharm; 2020 Oct; 17(10):3845-3856. PubMed ID: 32902989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ammonium carbamates as highly active transdermal permeation enhancers with a dual mechanism of action.
    Novotný M; Klimentová J; Janůšová B; Palát K; Hrabálek A; Vávrová K
    J Control Release; 2011 Mar; 150(2):164-70. PubMed ID: 21093505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing effects of medium chain aliphatic alcohols and esters on the permeation of 6-carboxyfluorescein and indomethacin through rat skin.
    Seki T; Morimoto K
    Drug Deliv; 2003; 10(4):289-93. PubMed ID: 14612346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of a tulobuterol patch with improved mechanical properties: effect of transdermal permeation enhancers on the release process of metal ligand-based acrylic pressure-sensitive adhesives.
    Nan L; Song H; Wang H; Mi R; Wang X; Fang L
    Drug Deliv Transl Res; 2024 Mar; 14(3):802-811. PubMed ID: 38082031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrophilic Ionic Liquids as Ingredients of Gel-Based Dermal Formulations.
    Dobler D; Schmidts T; Zinecker C; Schlupp P; Schäfer J; Runkel F
    AAPS PharmSciTech; 2016 Aug; 17(4):923-31. PubMed ID: 27435197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.